Is Neurofibromatosis Type 1-Noonan Syndrome a Phenotypic Result of Combined Genetic and Epigenetic Factors?

被引:0
|
作者
Yapijakis, Christos [1 ]
Pachis, Nikos [1 ]
Natsis, Stavros [1 ]
Voumvourakis, Costas [1 ]
机构
[1] Univ Athens, Eginit Hosp, Sch Med, Dept Neurol, GR-11528 Athens, Greece
来源
IN VIVO | 2016年 / 30卷 / 03期
关键词
Neurofibromatosis type 1; Noonan syndrome; epigenetic factors; NF1; gene; MUTATIONS CAUSE NOONAN; OF-FUNCTION MUTATIONS; NF1; GENE; NONSENSE MUTATION; FAMILY; DISORDERS; PTPN11; DIAGNOSIS; ARG-1947; PATHWAY;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background/Aim: Neurofibromatosis 1-Noonan syndrome (NFNS) presents combined characteristics of both autosomal dominant disorders: NF1 and Noonan syndrome (NS). The genes causing NF1 and NS are located on different chromosomes, making it uncertain whether NFNS is a separate entity as previously suggested, or rather a clinical variation. Patients and Methods: We present a four-membered Greek family. The father was diagnosed with familial NF1 and the mother with generalized epilepsy, being under hydantoin treatment since the age of 18 years. Their two male children exhibited NFNS characteristics. Results: The father and his sons shared R1947X mutation in the NF1 gene. The two children with NFNS phenotype presented with NF1 signs inherited from their father and fetal hydantoin syndrome-like phenotype due to exposure to that anticonvulsant during fetal development. Conclusion: The NFNS phenotype may be the result of both a genetic factor (mutation in the NF1 gene) and an epigenetic/environmental factor (e.g. hydantoin).
引用
收藏
页码:315 / 320
页数:6
相关论文
共 50 条
  • [1] A Rare Cause of Pheochromocytoma; Neurofibromatosis Type 1-Noonan Syndrome
    Tuna, Mazhar Muslum
    Basaran, Mehtap Navdar
    Dogan, Bercem Aycicek
    Karakilic, Ersen
    Cavdarli, Busranur
    Tutuncu, Yasemin
    Berker, Dilek
    Guler, Serdar
    [J]. HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2014, 52 (03): : 227 - 231
  • [2] Neurofibromatosis-Noonan Syndrome: A Possible Paradigm of the Combination of Genetic and Epigenetic Factors
    Yapijakis, Christos
    Pachis, Nikos
    Voumvourakis, Costas
    [J]. GENEDIS 2016: GENETICS AND NEURODEGENERATION, 2017, 987 : 151 - 159
  • [3] Exclusion of allelism of Noonan syndrome and neurofibromatosis-type 1 in a large family with Noonan syndrome neurofibromatosis association
    Bahuau, M
    Flintoff, W
    Assouline, B
    Lyonnet, S
    LeMerrer, M
    Prieur, M
    GuilloudBataille, M
    Feingold, N
    Munnich, A
    Vidaud, M
    Vidaud, D
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1996, 66 (03): : 347 - 355
  • [4] Diffuse-type tenosynovial giant cell tumor in association with neurofibromatosis type 1-Noonan syndrome: Possibly more than a chance relationship
    Posligua, Lorena
    McDonald, Douglas J.
    Dehner, Louis P.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (06) : 734 - 738
  • [5] The molecular profile of Polish patients with neurofibromatosis type 1 and neurofibromatosis-Noonan syndrome: do additional genetic factors affect the phenotypic variability among NF1-positive patients?
    Pelc, M.
    Halat-Wolska, P.
    Wicher, D.
    Ciara, E.
    Kosinska, J.
    Stawinski, P.
    Cieslikowska, A.
    Piekutowska-Abramczuk, D.
    Jurkiewicz, D.
    Siestrzykowska, D.
    Chalupczynska, B.
    Rydzanicz, M.
    Kowalski, P.
    Jedrzejowska, M.
    Ploski, R.
    Krajewska-Walasek, M.
    Chrzanowska, K.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 369 - 369
  • [6] CLINICAL VARIABILITY OF TYPE-1 NEUROFIBROMATOSIS - IS THERE A NEUROFIBROMATOSIS-NOONAN SYNDROME
    STERN, HJ
    SAAL, HM
    LEE, JS
    FAIN, PR
    GOLDGAR, DE
    ROSENBAUM, KN
    BARKER, DF
    [J]. JOURNAL OF MEDICAL GENETICS, 1992, 29 (03) : 184 - 187
  • [7] Phenotypic and genetic features in neurofibromatosis type 1 in children
    Duat Rodriguez, A.
    Martos Moreno, G. A.
    Martin Santo-Domingo, Y.
    Hernandez Martin, A.
    Espejo-Saavedra Roca, J. M.
    Ruiz-Falco Rojas, M. L.
    Argente, J.
    [J]. ANALES DE PEDIATRIA, 2015, 83 (03): : 173 - 182
  • [8] Patient with a neurofibromatosis type 1 mutation but a clinical diagnosis of Noonan syndrome
    Croonen, Ellen A.
    Yntema, Helger G.
    van Minkelen, Rick
    van den Ouweland, Ans M. W.
    van der Burgt, Ineke
    [J]. CLINICAL DYSMORPHOLOGY, 2012, 21 (04) : 212 - 214
  • [9] Graves' disease and hyperprolactinemia in a patient with Noonan syndrome neurofibromatosis type 1
    Bolko, P
    Wasko, R
    Waligórska, J
    Narozna, J
    Sowinski, J
    [J]. ANNALES D ENDOCRINOLOGIE, 2004, 65 (02) : 121 - 124
  • [10] ABSENCE OF LINKAGE OF NOONAN SYNDROME TO THE NEUROFIBROMATOSIS TYPE-1 LOCUS
    SHARLAND, M
    TAYLOR, R
    PATTON, MA
    JEFFERY, S
    [J]. JOURNAL OF MEDICAL GENETICS, 1992, 29 (03) : 188 - 190